| SENSITIVITY AND SPECIFICITY OF CHEST IMAGING FOR SCREENING FOR SARCOIDOSIS IN PATIENTS WITH CARDIAC PRESENTATIONS |
4 |
| A PROSPECTIVE STUDY OF PATIENTS DIAGNOSED WITH SARCOIDOSIS: FACTORS - ENVIRONMENTAL EXPOSURE, HEALTH ASSESSMENT, AND GENETIC OUTLOOKS |
4 |
| LUNG TRANSPLANTATION FOR PULMONARY SARCOIDOSIS |
3 |
| OUTCOME OF PATIENTS WITH SARCOIDOSIS REFRACTORY TO TNF ANTAGONISTS: A CASE SERIES |
2 |
| A COMPARISON TRIAL OF EIGHT WEEKS VERSUS TWELVE WEEKS OF EXERCISE PROGRAM IN INTERSTITIAL LUNG DISEASES |
2 |
| NEUROSARCOIDOSIS IN A PUBLIC SAFETY NET HOSPITAL: A STUDY OF 82( )CASES |
2 |
| MUSCULOSKELETAL AND PULMONARY OUTCOMES OF SARCOIDOSIS AFTER INITIAL PRESENTATION OF OSSEOUS INVOLVEMENT |
2 |
| ASSOCIATIONS OF LIPOPROTEIN SUBCLASSES AND OXIDATIVE STRESS STATUS IN PULMONARY AND PULMONARY PLUS EXTRAPULMONARY SARCOIDOSIS |
2 |
| LUNG MANIFESTATIONS OF IGG4-RELATED DISEASE. A MULTIFACETED DISORDER. PRESENTATION OF TWO CASES AND SHORT REVIEW OF THE LITERATURE |
2 |
| DIFFUSE BRONCHIECTASIS AND AIRFLOW OBSTRUCTION IN GRANULOMATOSIS WITH POLYANGIITIS |
2 |
| CLINICAL CHARACTERISTICS OF BIOPSY-PROVEN RENAL SARCOIDOSIS IN JAPAN |
2 |
| RADIOLOGIC AND PATHOLOGIC CHARACTERISTICS OF MYELOPEROXIDASE-ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED INTERSTITIAL LUNG DISEASE: A RETROSPECTIVE ANALYSIS |
2 |
| EFFECTIVENESS AND TOLERABILITY OF METHOTREXATE IN PULMONARY SARCOIDOSIS: A SINGLE CENTER REAL-WORLD STUDY |
2 |
| PIRFENIDONE IN CHRONIC HYPERSENSITIVITY PNEUMONITIS: A REAL-LIFE EXPERIENCE |
2 |
| MULTIDISCIPLINARY MANAGEMENT OF INTERSTITIAL LUNG DISEASES: A REAL-LIFE STUDY |
2 |
| CATHEPSIN S, A NEW SERUM BIOMARKER OF SARCOIDOSIS DISCOVERED BY TRANSCRIPTOME ANALYSIS OF ALVEOLAR MACROPHAGES |
1 |
| CASE STUDY: CARDIAC SARCOIDOSIS RESOLVED WITH MYCOBACTERIUM AVIUM PARATUBERCULOSIS ANTIBIOTICS (MAP) |
1 |
| NOD2/CARD15 gene polymorphisms and sarcoidosis susceptibility: review and meta- analysis |
1 |
| TYPE 2 MACROPHAGES AND TH2 CD4+CELLS IN INTERSTITIAL LUNG DISEASES (ILDS): AN OVERVIEW |
1 |
| CIGARETTE SMOKING AND RISK OF PRIMARY SYSTEMIC VASCULITIS: A PROPENSITY SCORE MATCHING ANALYSIS |
1 |
| ROLE OF CYTOMORPHOLOGY IN DIFFERENTIATING SARCOIDOSIS AND TUBERCULOSIS IN SUBJECTS UNDERGOING ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION |
1 |
| INTERSTITIAL LUNG DISEASES ASSOCIATED WITH METAL CONTENT IN SILICONE BREAST IMPLANTS: A CASE SERIES |
1 |
| NECROTISING SARCOID GRANULOMATOSIS. A RARE GRANULOMATOUS DISEASE |
1 |
| PRESENCE OF ONCONEURAL ANTIBODIES IN SARCOIDOSIS PATIENTS WITH PARASARCOIDOSIS SYNDROME |
1 |
| ASSOCIATION BETWEEN RS1800795 POLYMORPHISMS IN THE INTERLEUKIN-6 GENE AND VASCULITIS: A META-ANALYSIS |
1 |
| COEXISTENT TAKAYASU ARTERITIS AND SARCOIDOSIS: A CASE REPORT AND REVIEW OF THE LITERATURE |
1 |
| EVERYDAY COGNITIVE FAILURE IN PATIENTS SUFFERING FROM NEUROSARCOIDOSIS |
1 |
| DIAGNOSTIC MANAGEMENT OF OCCULT NODAL LYMPHANGIOLEIOMYOMATOSIS DETECTED DURING PELVIC CANCER STAGING. LOCALIZED FINDING OR SYSTEMIC DISEASE? |
1 |
| NEWLY DEFINED ACUTE EXACERBATION OF IDIOPATHIC PULMONARY FIBROSIS WITH SURGICALLY-PROVEN USUAL INTERSTITIAL PNEUMONIA: RISK FACTORS AND OUTCOME |
1 |
| IDENTIFICATION OF APOLIPOPROTEIN A-I IN BALF AS A BIOMARKER OF SARCOIDOSIS |
1 |
| VOLUMETRIC FDG PET ANALYSIS OF GLOBAL LUNG INFLAMMATION: NEW TOOL FOR PRECISION MEDICINE IN PULMONARY SARCOIDOSIS? |
1 |
| COMBINED PIRFENIDONE, AZITHROMYCIN AND PREDNISOLONE IN POST-H1N1 ARDS PULMONARY FIBROSIS |
1 |
| SARCOIDOSIS WITH ANKYLOSING SPONDYLITIS: CHANGING THERAPEUTIC LANDSCAPE |
1 |
| SARCOIDOSIS IN THE UNITED STATES MILITARY HEALTH SYSTEM |
1 |
| A COMMON MICROBIAL SIGNATURE IS PRESENT IN THE LOWER AIRWAYS OF INTERSTITIAL LUNG DISEASES INCLUDING SARCOIDOSIS |
1 |
| SARCOIDOSIS INORGANIC DUST EXPOSURE AND CONTENT OF BRONCHOALVEOLAR LAVAGE FLUID: THE MINASARC PILOT STUDY |
0 |
| DETERMINATION OF THE SMALLEST DETECTABLE CHANGE (SDC) AND THE MINIMAL IMPORTANT DIFFERENCE (MID) FOR THE SMALL FIBER NEUROPATHY SCREENING LIST (SFNSL) IN SARCOIDOSIS |
0 |
| ACUTE RESPIRATORY FAILURE DUE TO DIFFUSE PARENCHYMAL LUNG DISEASES IN A RESPIRATORY INTENSIVE CARE UNIT OF NORTH INDIA |
0 |
| QUANTITATIVE INTERPRETATION OF FDG PET FOR CARDIAC SARCOIDOSIS RECLASSIFIES VISUALLY INTERPRETED EXAMS AND POTENTIALLY IMPACTS DOWNSTREAM INTERVENTIONS |
0 |
| SARCOIDOSIS AND COLON CANCER: A POSSIBLE ASSOCIATION |
0 |
| HO-1 PROTECTS SMOKERS EXPOSED TO ARTIFICIAL STONE DUST FOR PULMONARY FUNCTION TESTS DETERIORATION |
0 |
| HIGH MOBILITY GROUP BOX 1 PROTEIN IN BRONCHOALVEOLAR LAVAGE FLUID AND CORRELATION WITH OTHER INFLAMMATORY MARKERS IN PULMONARY DISEASES |
0 |
| PROCEEDINGS OF THE AMERICAS ASSOCIATION OF SARCOIDOSIS AND OTHER GRANULOMATOUS DISEASES (AASOG) 2017 ANNUAL MEETING |
0 |
| EFFECT OF PULMONARY REHABILITATION ON FUNCTIONAL EXERCISE CAPACITY AND HYPOXEMIA IN PATIENTS WITH INTERSTITIAL LUNG DISEASES: A RETROSPECTIVE STUDY |
0 |
| A 12-WEEK COMBINATION OF CLARITHROMYCIN AND PREDNISONE COMPARED TO A 24-WEEK PREDNISONE ALONE TREATMENT IN CRYPTOGENIC AND RADIATION-INDUCED ORGANIZING PNEUMONIA |
0 |
| CHARACTERIZATION OF LYMPHANGIOLEIOMYOMATOSIS PATIENTS WITH DISCORDANCE BETWEEN SPIROMETRIC AND DIFFUSION MEASUREMENTS OF PULMONARY FUNCTION |
0 |
| RISK OF GASTROINTESTINAL EVENTS AMONG PATIENTS WITH SARCOIDOSIS: A POPULATION-BASED STUDY 1976-2013 |
0 |
| SARCOIDOSIS OF THE EXTERNAL NOSE: THE ROLE OF PHARMACOLOGIC RHINOPLASTY IN DIAGNOSIS AND TREATMENT |
0 |
| CIRCULATORY TGF-beta 1 IS SIGNIFICANTLY HIGHER IN EARLY STAGE OF PULMONARY SARCOIDOSIS |
0 |
| AIRWAY-CENTERED INTERSTITIAL FIBROSIS - AN UNDER-RECOGNIZED SUBTYPE OF DIFFUSE PARENCHYMAL LUNG DISEASES |
0 |
